BCR and B-cell chronic lymphocytic leukemia: The results we obtained showing differential sensitivity to cyclosporine A, FK506, and rapamycin in murine BL- and B-CLL–like tumors suggest that the two signals derived from the BCR involve the activation of different transduction pathways.